Translating biased agonists from molecules to medications: Serotonin 5-HT1A receptor functional selectivity for CNS disorders

A Newman-Tancredi, RY Depoortère… - Pharmacology & …, 2022 - Elsevier
Biased agonism (or “functional selectivity”) at G-protein-coupled receptors has attracted
rapidly increasing interest as a means to improve discovery of more efficacious and safer …

Finely-tuned gamma oscillations: Spectral characteristics and links to dyskinesia

C Wiest, F Torrecillos, G Tinkhauser, A Pogosyan… - Experimental …, 2022 - Elsevier
Gamma oscillations comprise a loosely defined, heterogeneous group of functionally
different activities between 30 and 100 Hz in the cortical and subcortical local field potential …

Emerging immunotherapies for Parkinson disease

SMA Zella, J Metzdorf, E Ciftci, F Ostendorf… - Neurology and …, 2019 - Springer
Symptomatic treatment options for Parkinson disease have steadily improved, and
individualized therapeutic approaches are becoming established for every stage of the …

Oscillations in cortico-basal ganglia circuits: implications for Parkinson's disease and other neurologic and psychiatric conditions

P Halje, I Brys, JJ Mariman… - Journal of …, 2019 - journals.physiology.org
Cortico-basal ganglia circuits are thought to play a crucial role in the selection and control of
motor behaviors and have also been implicated in the processing of motivational content …

The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic effects in MPTP-treated macaques

R Depoortere, TH Johnston, SH Fox… - Parkinsonism & related …, 2020 - Elsevier
Background Long-term treatment of Parkinson's disease (PD) with l-DOPA typically leads to
development of l-DOPA induced dyskinesia (LID). Amantadine, an NMDA antagonist …

[HTML][HTML] The selective 5-HT1A receptor agonist, NLX-112, exerts anti-dyskinetic and anti-parkinsonian-like effects in MPTP-treated marmosets

R Fisher, A Hikima, R Morris, MJ Jackson, S Rose… - …, 2020 - Elsevier
Abstract l-DOPA is the gold-standard pharmacotherapy for treatment of Parkinson's disease
(PD) but can lead to the appearance of troubling dyskinesia which are attributable to 'false …

Significance and translational value of high-frequency cortico-basal ganglia oscillations in Parkinson's disease

P Petersson, P Halje, MA Cenci - Journal of Parkinson's …, 2019 - journals.sagepub.com
The mechanisms and significance of basal ganglia oscillations is a fundamental research
question engaging both clinical and basic investigators. In Parkinson's disease (PD), neural …

Basal ganglia oscillations as biomarkers for targeting circuit dysfunction in Parkinson's disease

P Petersson, AA Kühn, WJ Neumann… - Progress in brain research, 2020 - Elsevier
Oscillations are a naturally occurring phenomenon in highly interconnected dynamical
systems. However, it is thought that excessive synchronized oscillations in brain circuits can …

Serotonin 5-HT1A receptor biased agonists: The challenge of translating an innovative neuropharmacological concept into therapeutics

L Zimmer, A Newman-Tancredi - Neuropharmacology, 2024 - Elsevier
Serotonin 5-HT 1A receptor agonists are prime candidates for CNS drug discovery due to
their involvement physiological and pathological processes relevant to neurology and …